The maximum recommended daily dose of this drug is 75 mg. Taking more than 75 mg per day, or exceeding the daily dose recommended by a physician based···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 170
If one dose is missed during treatment, continue with the original drug dosage and administration schedule.Do not take a double dose at one time to av···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 161
The elimination half-life of this product is 21–32 hours, meaning it takes 21–32 hours for the plasma drug concentration or total body drug level to d···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 166
After oral administration, the drug reaches peak plasma concentration in patients within 2–6 hours. Platelet counts begin to increase within 1–2 weeks···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 158
According to research data:In healthy volunteers taking standard doses, the half-life of the drug (time required for the concentration in the body to ···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 159
Currently, there is no established treatment plan for an overdose of this medication. According to early studies: When healthy individuals took a sing···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 166
The medication should be taken at a fixed time every day. If the forgotten time is less than 12 hours, you can take the missed dose immediately. If th···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 161
In healthy individuals taking the drug on an empty stomach, it is rapidly absorbed, typically reaching peak concentration in the blood between half an···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 163
Approval AnnouncementNovember 20, 2015 -- Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two ···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 196
Study Overview and Release ContextTakeda Pharmaceutical Company Limited, a Japanese pharmaceutical enterprise, recently announced the results of two c···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 202
Overview of Empliciti Triple TherapyEmpliciti is a multiple myeloma therapy developed by Bristol-Myers Squibb (BMS). The U.S. regulatory authorities h···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 180
Approval OverviewRecently, the Committee for Medicinal Products for Human Use (CHMP) of the European Union has granted a positive opinion for the trip···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 178
Approval AnnouncementMay 25, 2020 — Bristol-Myers Squibb (BMS) recently announced that the U.S. Food and Drug Administration (FDA) has approved Pomaly···【Read More】
Update: 2026-03-18Source: Haiou HealthViews: 214
Taking pomalidomide with other drugs that cause dizziness or confusion can worsen these effects. Ask your doctor before using opioid medication, a sle···【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 198
Do not donate blood or sperm while you are using pomalidomide.Avoid driving or hazardous activity until you know how pomalidomide will affect you. You···【Read More】
Update: 2026-03-17Source: Haiou HealthViews: 197
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos